Podcast: Irresistible cancer therapies w/Nick Goldner

Check out this episode of Translation by our partners at 50 years about how our Founders, Nick Goldner and Chris Bulow, went from getting PhDs studying antibiotic resistance to starting a company whose sole mission is to develop novel